Autoimmune inner ear disease (AIED) is a rare condition distinguished by the immune system’s erroneous attack on the inner ear. This response can result in symptoms such as hearing loss, tinnitus, and dizziness. AIED affects less than one percent of the millions of Americans experiencing hearing loss, with a slightly higher prevalence found in middle-aged women.
Common Symptoms of Autoimmune Inner Ear Disease
People diagnosed with Autoimmune Inner Ear Disease (AIED) typically experience hearing loss in one ear and progress to the other. This transition may occur over several weeks or extend over several months.
• Hearing loss in one or both ears
• Feelings of fullness in the ear
• Vertigo
• Dizziness
• Balance issues
• Tinnitus
What Can Cause Autoimmune Inner Ear Disease?
The immune cells in the human body continuously monitor for invading pathogens. However, these cells may mistakenly identify the cells within the inner ear as viral or bacterial invaders, leading to an autoimmune reaction wherein they attack healthy ear cells. This immune response can also have detrimental effects on other organs. Notably, approximately 30% of individuals diagnosed with Autoimmune Inner Ear Disease (AIED) concurrently experience other autoimmune disorders that can affect multiple systems within the body. Such disorders may include lupus, rheumatoid arthritis, ulcerative colitis, scleroderma, or Sjögren’s syndrome (chronic dry eyes).
Diagnosing AIED
Due to the commonality of its symptoms, Autoimmune Inner Ear Disease can pose challenges in obtaining an accurate diagnosis. AIED is frequently misdiagnosed as an ear infection until hearing loss has progressed to involve the second ear. To diagnose AIED, a physician will inquire about the patient’s health and medical history, conduct a physical examination, and perform a hearing assessment. Additionally, they will evaluate the patient’s balance, which can indicate communication effectiveness between the inner ear and the brain. Blood tests may also be part of the diagnostic process. There is currently no definitive test available to identify AIED; however, diagnostic results may suggest the presence of an autoimmune response. In such instances, seeking the expertise of an otolaryngologist (ear specialist) with specialized training in autoimmune disorders is advisable. Your physician may initiate treatment before achieving a definitive diagnosis. This proactive approach helps to prevent irreversible damage to hearing. It is not uncommon for people to receive a diagnosis of AIED only after initiating treatment, at which point they may show an improvement in their symptoms.
Treatment Options For AIED
Your physician is likely to prescribe a medication aimed at alleviating inflammation. High doses of corticosteroids have shown effectiveness for autoimmune inner ear disease (AIED). Unfortunately, these medications are associated with numerous side effects. Consequently, their use should be limited to a few weeks. Following the use of steroids, it is common for a physician to prescribe additional medication aimed at moderating the immune response. Medications such as cyclophosphamide (Cytoxan), azathioprine (Imuran), and methotrexate frequently are utilized for this purpose. Hearing aids can assist in managing hearing loss; however, a physician may recommend a cochlear implant for individuals with more severe cases. This device stimulates the auditory nerves in the inner ear, which transmit auditory signals. One cochlear implant component goes behind the ear, with the other implanted beneath the skin.
As medical science expands the understanding of Autoimmune Inner Ear Disease, it may bring about a more extensive array of treatment options. These may encompass pharmacological interventions that demonstrate enhanced efficacy with reduced adverse effects. The application of gene therapy could facilitate the restoration of functionality in damaged auditory cells.
Frequently Asked Questions
Autoimmune Inner Ear Disease (AIED) is a rare condition in which the body's immune system mistakenly attacks the inner ear, causing symptoms such as hearing loss, tinnitus, dizziness, and balance issues. It affects less than one percent of people with hearing loss, with a slightly higher prevalence in middle-aged women.
People with AIED typically experience hearing loss initially in one ear, which then progresses to the other ear over weeks or months. Other common symptoms include feelings of ear fullness, vertigo, dizziness, balance difficulties, and tinnitus (ringing in the ears).
Diagnosing AIED can be challenging because its symptoms overlap with other ear conditions. Doctors use a combination of medical history review, physical exams, hearing tests, balance assessments, and blood tests. Since there is no definitive diagnostic test, an otolaryngologist with expertise in autoimmune disorders may be consulted, and treatment may start before a definitive diagnosis to prevent hearing damage.
In AIED, the immune system wrongly identifies cells in the inner ear as threats such as viruses or bacteria and attacks them. This autoimmune response can also coincide with other autoimmune diseases like lupus or rheumatoid arthritis, affecting multiple body systems.
Treatment for AIED typically starts with high doses of corticosteroids to reduce inflammation, although these have side effects and are used short-term. Immunosuppressive medications like cyclophosphamide, azathioprine, or methotrexate may be prescribed afterward. Hearing aids can help manage hearing loss, and cochlear implants may be recommended for severe cases. Future treatments may include gene therapy and more effective drugs with fewer side effects.
Yes, approximately 30% of people with AIED also have other autoimmune disorders such as lupus, rheumatoid arthritis, or Sjögren's syndrome, which can affect various organs beyond the ear. This overlap indicates AIED can be part of a broader systemic autoimmune condition.
Starting treatment early in AIED is crucial to prevent irreversible hearing damage. Because diagnosis can be difficult and delayed, physicians often begin anti-inflammatory therapy as soon as AIED is suspected to try to preserve hearing and improve symptoms.
